Get the Stockscreener App
5.90
48.99%
1.94
After Hours:
5.90
Sonnet Biotherapeutics Holdings Inc stock is traded at $5.90, with a volume of 7.49M.
It is up +48.99% in the last 24 hours and up +97.32% over the past month.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
See More
Previous Close:
$3.96
Open:
$4.15
24h Volume:
7.49M
Relative Volume:
1.90
Market Cap:
$40.28M
Revenue:
$129.20K
Net Income/Loss:
$-7.44M
P/E Ratio:
-0.5273
EPS:
-11.19
Net Cash Flow:
$-8.62M
1W Performance:
+107.02%
1M Performance:
+97.32%
6M Performance:
+324.46%
1Y Performance:
-7.89%
1-Day Range:
$3.97
$6.65
1-Week Range:
$2.98
$6.65
52-Week Range:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Name
Sonnet Biotherapeutics Holdings Inc
Sector
Industry
Phone
609-375-2227
Address
100 OVERLOOK CENTER, PRINCETON, NJ
Compare SONN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
5.90 | 23.83M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Latest News
What’s the analyst consensus on Cybin Inc.Quarterly Risk Review & Comprehensive Market Scan Insights - Lancaster City Council
Multi Factor Analysis Ranks Sonnet BioTherapeutics Holdings Inc. as Strong BuyJuly 2025 Snapshot & Stepwise Trade Signal Guides - beatles.ru
Is Sonnet BioTherapeutics Holdings Inc. a candidate for recovery play2025 Breakouts & Breakdowns & Intraday High Probability Alerts - Newser
Analyzing net buyer seller activity in Sonnet BioTherapeutics Holdings Inc.Market Activity Summary & Low Risk High Win Rate Stock Picks - Newser
Is Sonnet BioTherapeutics Holdings Inc. gaining market shareTrend Reversal & Low Drawdown Momentum Ideas - خودرو بانک
Will Sonnet BioTherapeutics Holdings Inc. benefit from rising consumer demandAnalyst Upgrade & High Accuracy Trade Signal Alerts - خودرو بانک
What is Sonnet BioTherapeutics Holdings Inc. s 5 year growth outlook2025 Market Sentiment & Accurate Intraday Trade Tips - خودرو بانک
Is Sonnet BioTherapeutics Holdings Inc. undervalued by DCF analysis2025 Technical Patterns & AI Powered Market Entry Strategies - خودرو بانک
Has Sonnet BioTherapeutics Holdings Inc. found a price floorWeekly Trend Summary & Safe Entry Trade Signal Reports - Newser
Is Sonnet BioTherapeutics Holdings Inc. still worth holding after the dip2025 Breakouts & Breakdowns & High Accuracy Swing Trade Signals - Newser
How liquid is Sonnet BioTherapeutics Holdings Inc. stock2025 Sector Review & Real-Time Stock Price Movement Reports - خودرو بانک
How to track smart money flows in Sonnet BioTherapeutics Holdings Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionQuarterly Profit Summary & Short-Term Trading Alerts - Newser
Is Sonnet BioTherapeutics Holdings Inc. forming a bottoming baseJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - Newser
Analyzing drawdowns of Sonnet BioTherapeutics Holdings Inc. with statistical toolsPortfolio Update Report & Growth Oriented Trade Recommendations - Newser
Is Sonnet BioTherapeutics Holdings Inc. trading at a discountEarnings Performance Report & Smart Swing Trading Alerts - خودرو بانک
Understanding Sonnet BioTherapeutics Holdings Inc.’s price movement2025 Pullback Review & Risk Managed Trade Strategies - Newser
Real time pattern detection on Sonnet BioTherapeutics Holdings Inc. stockTrade Entry Report & Verified Swing Trading Watchlist - Newser
Is a relief rally coming for Sonnet BioTherapeutics Holdings Inc. holders2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Earnings visualization tools for Sonnet BioTherapeutics Holdings Inc.July 2025 Opening Moves & Weekly High Return Stock Forecasts - Newser
Is Sonnet BioTherapeutics Holdings Inc. building a consolidation baseWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Will Sonnet BioTherapeutics Holdings Inc. announce a stock splitMarket Sentiment Report & Real-Time Market Trend Scan - خودرو بانک
Has Sonnet BioTherapeutics Holdings Inc. formed a bullish divergenceQuarterly Profit Review & Expert Approved Momentum Ideas - Newser
What machine learning models say about Sonnet BioTherapeutics Holdings Inc.2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser
Quarterly Risk: What makes Sonnet BioTherapeutics Holdings Inc. stock attractive today2025 Pullback Review & Weekly Setup with High ROI Potential - خودرو بانک
Aug Mood: Can Sonnet BioTherapeutics Holdings Inc. generate free cash flowJuly 2025 Action & Weekly Consistent Profit Watchlists - خودرو بانک
Is Sonnet BioTherapeutics Holdings Inc. stock a good dividend stockMarket Risk Analysis & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Technical signs of recovery in Sonnet BioTherapeutics Holdings Inc.2025 AllTime Highs & Detailed Earnings Play Strategies - Newser
Detecting support and resistance levels for Sonnet BioTherapeutics Holdings Inc.July 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
How sensitive is Sonnet BioTherapeutics Holdings Inc. to inflation2025 Price Momentum & Precise Entry and Exit Recommendations - خودرو بانک
Sonnet BioTherapeutics Holdings Inc. stock prediction for this week2025 Key Highlights & Risk Controlled Stock Alerts - Newser
AI Indicators Detect Buy Opportunity in Sonnet BioTherapeutics Holdings Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Sonnet BioTherapeutics Holdings Inc. stock daily chart insightsGold Moves & Safe Capital Investment Plans - Newser
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):